tradingkey.logo
tradingkey.logo

Cadrenal Therapeutics Announces Clinical Trial Initiation Plans For Tecarfarin In Patients With End-Stage Kidney Disease (Eskd) Transitioning To Dialysis

ReutersAug 5, 2025 11:48 AM

- Cadrenal Therapeutics Inc CVKD.O:

  • CADRENAL THERAPEUTICS ANNOUNCES CLINICAL TRIAL INITIATION PLANS FOR TECARFARIN IN PATIENTS WITH END-STAGE KIDNEY DISEASE (ESKD) TRANSITIONING TO DIALYSIS

  • CADRENAL THERAPEUTICS INC - ENROLLMENT FOR TECARFARIN TRIAL TO BEGIN LATER THIS YEAR

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI